Novel therapeutic agents for the treatment of hbv infection

A compound of Formula (I) or an N-oxide thereof, or a pharmaceutically acceptable salt, stereoisomer, solvate, polymorph or tautomer of said compound of Formula (I) or N-oxide thereof:

• wherein
• R1 is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, halo, nitro, oxo, cyano, —(CH2)pRa, —ORa, —SRa, —NH(CH2)pRa, —C(O)Ra, —S(O)Ra, —SO2Ra, —C(O)ORa, —OC(O)Ra, —NRbRc, —P(O)RbRc, —C(O)N(Rb)Rc, —N(Rb)C(O)Rc, —SO2N(Rb)Rc, or —N(Rb)SO2Rc, in which said alkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl is optionally subsitiuted with one or more Rd;
• R5 is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, —(CH2)pRa, —C(O)Ra, —S(O)Ra, —SO2Ra, —C(O)ORa, —C(O)N(Rb)Rc, —SO2N(Rb)Rc, in which said alkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl is optionally subsitiuted with one or more Rd;
• each of p, and q, independently, is 0, 1, 2, 3, 4, 5, 6, 7, or 8;
• and
• Ra, Rb, Rc and Rd, independently, is H, D, alkyl, alkenyl, alkynyl, halo, cyano, amine, nitro, hydroxy, C(O)NHOH, alkoxy, alkoxyalkyl, haloalkyl, hydroxyalkyl, aminoalkyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonylamino, alkylamino, oxo, halo-alkylamino, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, or heteroaryl.